JP2003501480A - 静注用免疫グロブリンの製造方法および製剤 - Google Patents

静注用免疫グロブリンの製造方法および製剤

Info

Publication number
JP2003501480A
JP2003501480A JP2001502867A JP2001502867A JP2003501480A JP 2003501480 A JP2003501480 A JP 2003501480A JP 2001502867 A JP2001502867 A JP 2001502867A JP 2001502867 A JP2001502867 A JP 2001502867A JP 2003501480 A JP2003501480 A JP 2003501480A
Authority
JP
Japan
Prior art keywords
process according
solution
gamma globulin
fraction
globulin solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001502867A
Other languages
English (en)
Japanese (ja)
Inventor
アール．・マミジ ラジャ
アンドラニク・バグダサリアン
ゴルゴニオ・カナベラル
Original Assignee
アルファ・セラピューティック・コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルファ・セラピューティック・コーポレーション filed Critical アルファ・セラピューティック・コーポレーション
Publication of JP2003501480A publication Critical patent/JP2003501480A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
JP2001502867A 1999-06-15 2000-06-06 静注用免疫グロブリンの製造方法および製剤 Pending JP2003501480A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33328999A 1999-06-15 1999-06-15
US09/333,289 1999-06-15
PCT/US2000/011870 WO2000076534A1 (en) 1999-06-15 2000-06-06 Manufacturing method for intravenous immune globulin and resultant product

Publications (1)

Publication Number Publication Date
JP2003501480A true JP2003501480A (ja) 2003-01-14

Family

ID=23302162

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001502867A Pending JP2003501480A (ja) 1999-06-15 2000-06-06 静注用免疫グロブリンの製造方法および製剤

Country Status (13)

Country Link
EP (1) EP1185290A4 (cs)
JP (1) JP2003501480A (cs)
KR (1) KR20020010921A (cs)
CN (1) CN1358100A (cs)
AU (1) AU756071B2 (cs)
BR (1) BR0011648A (cs)
CA (1) CA2375560A1 (cs)
CZ (1) CZ20014456A3 (cs)
HK (1) HK1048252A1 (cs)
IL (1) IL146433A0 (cs)
PL (1) PL352910A1 (cs)
WO (1) WO2000076534A1 (cs)
ZA (1) ZA200110168B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2437518A (en) * 2006-04-26 2007-10-31 Noel Kavanagh Antiserum preparation
WO2007136327A1 (en) * 2006-05-22 2007-11-29 Ge Healthcare Bio-Sciences Ab A method of producing igg
US7932356B1 (en) * 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
EP3118210B1 (en) * 2014-03-11 2019-11-13 Green Cross Holdings Corporation Method for purifying immunoglobulin
EP3118209B1 (en) * 2014-03-11 2020-02-19 Green Cross Holdings Corporation Method for purifying immunoglobulin
KR101941974B1 (ko) * 2016-11-18 2019-01-24 주식회사 녹십자 혈장 단백질 정제시 fxi의 제거방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
FR2582515B1 (fr) * 1985-05-30 1988-11-04 Merieux Inst Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
EP0378208B2 (en) * 1989-01-13 2003-01-15 Mitsubishi Pharma Corporation Production method for protein-containing composition
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
US5110910A (en) * 1991-03-25 1992-05-05 Miles Inc. Virucidal euglobulin precipitation
DE4431833C1 (de) * 1994-09-07 1995-05-18 Blutspendedienst Der Drk Lande Verfahren zur Herstellung eines AHF-Konzentrates
UA64742C2 (uk) * 1997-12-24 2004-03-15 Альфа Терапевтик Корпорейшн СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ)

Also Published As

Publication number Publication date
EP1185290A4 (en) 2005-08-31
KR20020010921A (ko) 2002-02-06
BR0011648A (pt) 2002-03-19
CA2375560A1 (en) 2000-12-21
AU756071B2 (en) 2003-01-02
AU5722400A (en) 2001-01-02
CN1358100A (zh) 2002-07-10
PL352910A1 (en) 2003-09-22
ZA200110168B (en) 2002-08-26
WO2000076534A1 (en) 2000-12-21
IL146433A0 (en) 2002-07-25
EP1185290A1 (en) 2002-03-13
HK1048252A1 (zh) 2003-03-28
CZ20014456A3 (cs) 2002-05-15

Similar Documents

Publication Publication Date Title
US5177194A (en) Process for purifying immune serum globulins
JP5042817B2 (ja) ウイルス安全精製抗体調製物を提供する方法
JP2005500265A (ja) 治療的使用のためのヒト免疫グロブリン濃縮物の調製方法
EP1041998A1 (en) Composition and method for dermal and transdermal administration of a cytokine
JPH04243899A (ja) 第ｖｉｉｉ因子の精製およびこの方法で得られた第ｖｉｉｉ因子
KR960001473B1 (ko) 정맥 주사용 면역글로불린 제제의 제조 방법
JPH0676337B2 (ja) 高純度抗血友病性因子濃縮物の製造法
US6162904A (en) Manufacturing method for intraveneously administrable immune globulin and resultant product
RU2198668C2 (ru) Способ получения раствора гамма-глобулина, предназначенного для внутривенного введения, и продукт, получаемый этим способом
US6504012B2 (en) Method for preparing dual virally inactivated immune globulin for intravenous administration
KR101657690B1 (ko) 혈장 유래 b형 간염 사람 면역글로불린 제제의 제조방법
JP2003501480A (ja) 静注用免疫グロブリンの製造方法および製剤
MXPA99007835A (en) Production process for intravenous immune serum globulin and resultant product
JPH0761935A (ja) 静注用免疫グロブリン製剤の製造方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060818

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20071113

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080205

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091007

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100215